Authors


Gunnar Esiason

Latest:

Contributor: It’s Time to Talk About Paying Clinical Trial Participants More

There is wide variation in the governance over research participant pay, and with rapid advances in technology enabling trial access, industry should step up and pay patients what they are worth, says Gunnar Esiason, a patient advocate living with cystic fibrosis.


Anita H. Yuan, PhD, MPH

Latest:

Patients’ Needs Following Emergency Care for Ambulatory Care–Sensitive Conditions

To inform intervention development, we assessed for medication changes and patient care needs following treat-and-release Veterans Affairs emergency department visits for chronic ambulatory care–sensitive conditions.


Carmen A. Carrillo, MA, MHS

Latest:

Choosing Wisely Interventions to Reduce Antibiotic Overuse in the Safety Net

This study evaluates the impact of Choosing Wisely–based interventions on antibiotic prescribing for viral respiratory tract infections in a real-world safety-net setting.


Rahul Rastogi, MD

Latest:

Advanced Care at Home at Scale in an Integrated Health Care System

Advanced care at home (otherwise known as hospital at home) can be scaled and provide care for a sizable portion of a hospital’s inpatient census, creating hospital capacity in an integrated delivery system.


Bruce L. Jacobs, MD, MPH

Latest:

Comparison of Primary Payer in Cancer Registry and Discharge Data

Enrollment in managed care among Medicaid enrollees presents challenges to classifying Medicaid coverage in cancer registries.


Lionel Chow, MD, PhD

Latest:

Lessons From Previously Used Therapies In NF1-PN

Panelists discuss key lessons learned from previous NF1-associated plexiform neurofibroma therapies, including the limitations of traditional treatments due to high toxicity and limited efficacy, and how these challenges are driving the development of more targeted therapies like MEK inhibitors, personalized medicine, and combination strategies to improve outcomes and reduce relapse.


Lewei (Allison) Lin, MD

Latest:

Impact of COVID-19 on Specialty Televisits in a Large Integrated Health Care System

Specialty televisits remain common in the Veterans Health Administration following the COVID-19 pandemic, suggesting they will remain an important ongoing care modality for many patients.


Joseph Carrington, DO

Latest:

Telemetry: Appropriateness of Initial Assignment and Duration in Nonintensive Setting

The authors report overutilization of telemetry monitoring in a community setting, increasing the cost of health care and potential harm to patients with unnecessary interventions.


Glenn Wirick
Glenn Wirick

Latest:

Contributor: How to Become a Star Ratings “Triple Threat” With CAHPS, Medication Adherence, and an SDOH-First Approach to Member Engagement

Medicare Advantage plans can implement 3 simple steps to make sure that they are competitive in the modern Stars environment.


Shealeigh A. Inselman, BS

Latest:

Impact of Medical Care Coordination Intervention on Patient Activation

This observational evaluation compared an adult medical care coordination intervention with usual care and found that the intervention was associated with significant improvements in patient activation.



Jennifer Bautista, MD

Latest:

Service Line Care Delivery Model for COVID-19 Patient-Centric Care

The authors provide steps hospitals can take to align their care delivery model to effectively meet the demands of a public health crisis such as the current pandemic.


Hui-Jie Lee, PhD

Latest:

Systemic Treatments for Advanced Prostate Cancer: Relationship Between Health Insurance Plan and Treatment Costs

The authors examine how insurer and patient out-of-pocket payments for advanced prostate cancer differ by drug and health plan type and describe the relationship between these payments and utilization.


Oliver Díaz Espinosa, PhD

Latest:

Generalized Cost-Effectiveness Analysis to Assess Treatment Value in Hepatitis C

This article estimates the comprehensive value of direct-acting antivirals for the treatment of hepatitis C virus using a generalized cost-effectiveness analysis.


Kathryn Colborn, PhD, MSPH

Latest:

Modeling of an Alternative Reimbursement Method for Palliative Care

The authors modeled a version of the Patient and Caregiver Support for Serious Illness alternative reimbursement structure for palliative care using data from the Statin Trial.


William Hart-Davidson, PhD

Latest:

Type 2 Diabetes Patient Activation and mHealth Interventions Decreased Cardiovascular Disease Risk

Mobile health (mHealth) and a patient activation program could serve as a model for improving health outcomes for patients in outpatient clinical settings by decreasing atherosclerotic cardiovascular disease risk score.


Jill M. Killian, BS

Latest:

Patient-Centered Communication and Outcomes in Heart Failure

Among community patients living with heart failure, excellent and good patient-centered communication was associated with a reduced risk of death.


Harmit Patel, MS

Latest:

Post-SNF Outcomes and Cost Comparison: Medicare Advantage vs Traditional Medicare

Patients enrolled in Medicare Advantage had better outcomes and lower cost following skilled nursing facility (SNF) discharge than patients enrolled in traditional fee-for-service Medicare.



John Urwin, MD

Latest:

Organizational Capacity Among Hospitals in Medicare and Commercial Bundled Payments

A national survey demonstrated differences in organizational capacity between hospitals participating in Medicare bundled payment programs and those coparticipating in both Medicare and commercial bundled payment programs.


Brenda M. McGrath, PhD

Latest:

Cardiovascular Disease Risk Management During COVID-19: In-Person vs Virtual Visits

This article compares cardiovascular disease risk management in community clinics during the COVID-19 pandemic among patients for whom primary care was delivered mostly in person vs mostly virtually.


Danielle Haney, PhD

Latest:

Breaking Barriers: Partnerships to Improve Diabetic Eye Health in Alabama

This article reviews barriers to diabetic eye health across Alabama and highlights a partnership with Genentech and the American Diabetes Association to address this issue.


Maruf Haider, MD

Latest:

Service Line Care Delivery Model for COVID-19 Patient-Centric Care

The authors provide steps hospitals can take to align their care delivery model to effectively meet the demands of a public health crisis such as the current pandemic.


Matthew S. D. Kerr, PhD

Latest:

Flash CGM Associated With Event Reduction in Nonintensive Diabetes Therapy

Analysis of the MarketScan database showed a strong association between flash continuous glucose monitoring (CGM) use and significant reductions in diabetes-related events and hospitalizations in a cohort of 10,282 adults with type 2 diabetes.


Tamara Beetham, MPH

Latest:

Physician Response to COVID-19–Driven Telehealth Flexibility for Opioid Use Disorder

COVID-19–driven telehealth exposure positively shifted physician respondents’ perceptions of telehealth effectiveness, and most are likely to continue use if temporary telehealth regulatory flexibility is permanently extended.


Leslie P. Wong, MD, MBA

Latest:

Dialysis Costs for a Health System Participating in Value-Based Care

In a large, integrated health system participating in value-based care, higher costs and utilization were observed before and after unplanned dialysis initiation.


Sana M. Al-Khatib, MD, MHS

Latest:

Coverage With Evidence Development: Where Are We Now?

Review of CMS’ coverage with evidence development program exposes a need to improve program transparency and clarify requirements and timetables for reporting to improve access to novel therapies.


Julie Parsons, MD

Latest:

Final Panel Thoughts on the Management of SMA

Panelists discuss how spinal muscular atrophy (SMA) treatment will evolve over the next 5 years, likely incorporating improved gene therapy delivery systems, combination therapies, and rehabilitation models, while maintaining individualized approaches for each patient.


Shivani Misra, PhD

Latest:

Predicting Mortality Risk Using the PREVENT Equation Across Diverse Racial Groups

This study validates the Predicting Risk of CVD Events (PREVENT) score across diverse racial and ethnic populations, highlighting its effectiveness in predicting cardiovascular risk and mortality, regardless of race or ethnicity.


Marty J. Feltner, PharmD

Latest:

Key Takeaways on RSV Vaccination

The panel concludes its discussion by providing key takeaways on the evolving RSV vaccination landscape.

AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo